Pharmaceutical Macro Trends
- High Covid-19 patients requiring hospitalisation may result in an on-going drive to keep other patient conditions managed in a home environment
- GP consultation and diagnosis undertaken remotely likely to become the default method
- Further development of the home-diagnostic / self-medication sectors
- Stay at home culture driving a change in habits
Beyond Distribution
We strive to make the difference, supporting you beyond supply, we provide:
- GDP compliant (MHRA audited) / API Certified (FMD) / ISO 9001 certified
- APIs only from fully GMP-approved sources and thorough due-diligence applied
- Secure and transparent GMDP supply chains
- Experts in API approvals, regulatory/quality documentation assessments
- All volumes supplied (R&D, pilot production, commercial quantities)
- Global freight and transportation management to multiple end-user sites
Have You Tried?
through our extensive network of suppliers Surfachem supplies customers with an extensive range of active ingredients for their current portfolio and new product development requirements. We aim to provide you with a full package of regulatory and quality documentation to support your APIs. We go further to give you relevant product and market information that focuses on your needs.
The below active ingredients are distributed by Surfachem with CEP/EDMF and EU-GMP certification
| Therapeutic Area | Key API distributed by Surfachem |
|---|---|
| Acne & Rosacea | Adapalene |
| Anti-infective (eye) | Azithromycin |
| Anti-diabetic (sulfonylureas) | Glicazide |
| Anti-spasmodic | Glycopyrronium |
| Antiseptics and skin cleansers | Chlorhexidine Gluconate |
| Beta Blocker | Atenolol, Bisoprolol |
| Calcium Channel Blocker | Dilitiazem |
| Chronic Bowel Disorders | Mesalazine |
| Diuretics | Torasemide |
| Neuromuscular Disorders | Baclofen |
| Ear, Nose & Oropharynx | Amylmetacresol, Benzydamine, Chlorhexidine Gluconate |
| Laxative | Bisacodyl |
| Rheumatic disease, topical pain | Ketoprofen |
